The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Podocyte as the Target for Aldosterone: Roles of Oxidative Stress and Sgk1
Abstract
Accumulating evidence suggests that mineralocorticoid receptor blockade effectively reduces proteinuria in hypertensive patients. However, the mechanism of the antiproteinuric effect remains elusive. In this study, we investigated the effects of aldosterone on podocyte, a key player of the glomerular filtration barrier. Uninephrectomized rats were continuously infused with aldosterone and fed a high-salt diet. Aldosterone induced proteinuria progressively, associated with blood pressure elevation. Notably, gene expressions of podocyte-associated molecules nephrin and podocin were markedly decreased in aldosterone-infused rats at 2 weeks, with a gradual decrease thereafter. Immunohistochemical studies and electron microscopy confirmed the podocyte damage. Podocyte injury was accompanied by renal reduced nicotinamide-adenine dinucleotide phosphate oxidase activation, increased oxidative stress, and enhanced expression of aldosterone effector kinase Sgk1. Treatment with eplerenone, a selective aldosterone receptor blocker, almost completely prevented podocyte damage and proteinuria, with normalization of elevated reduced nicotinamide-adenine dinucleotide phosphate oxidase activity. In addition, proteinuria, podocyte damage, and Sgk1 upregulation were significantly alleviated by tempol, a membrane-permeable superoxide dismutase, suggesting the pathogenic role of oxidative stress. Although hydralazine treatment almost normalized blood pressure, it failed to improve proteinuria and podocyte damage. In cultured podocytes with consistent expression of mineralocorticoid receptor, aldosterone stimulated membrane translocation of reduced nicotinamide-adenine dinucleotide phosphate oxidase cytosolic components and oxidative stress generation in podocytes. Furthermore, aldosterone enhanced the expression of Sgk1, which was inhibited by mineralocorticoid receptor antagonist and tempol. In conclusion, podocytes are injured at the early stage in aldosterone-infused rats, resulting in the occurrence of proteinuria. Aldosterone can directly modulate podocyte function, possibly through the induction of oxidative stress and Sgk1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pickering, T. G., Hall, J. E., Appel, L. J., Falkner, B. E., Graves, J., Hill, M. N., Jones, D. W., Kurtz, T., Sheps, S. G., & Roccella, E. J. (2005) · Circulation · doi:10.1161/01.cir.0000154900.76284.f6 · Cited by 3,985
NAD(P)H Oxidase: Role in Cardiovascular Biology and Disease
Griendling, K. K., Sorescu, D., & Ushio-Fukai, M. (2000) · Circulation Research · doi:10.1161/01.res.86.5.494 · Cited by 2,886
Kestilä, M., Lenkkeri, U., Männikkö, M., Lamerdin, J., McCready, P., Putaala, H., Ruotsalainen, V., Morita, T., Nissinen, M., Herva, R., et al. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80057-x · Cited by 1,866
Cell biology of the glomerular podocyte
Pavenstädt, H., Kriz, W., & Kretzler, M. (2003) · Physiological Reviews · doi:10.1152/physrev.00020.2002 · Cited by 1,499
Pathophysiology of Progressive Nephropathies
Remuzzi, G., & Bertani, T. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811123392007 · Cited by 1,269
Mundel, P., Reiser, J., Borja, A. Z. M., Pavenstädt, H., Davidson, G. R., Kriz, W., & Zeller, R. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3739 · Cited by 877
Progression of glomerular diseases: Is the podocyte the culprit?
Kriz, W., Gretz, N., & Lemley, K. V. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00044.x · Cited by 592
From the Periphery of the Glomerular Capillary Wall Toward the Center of Disease
Wolf, G., Chen, S., & Ziyadeh, F. N. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1626 · Cited by 565
Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats
Blasi, E. R., Rocha, R., Rudolph, A. E., Blomme, E. A. G., Polly, M. L., & McMahon, E. G. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00929.x · Cited by 542
Nishiyama, A., Yao, L., Nagai, Y., Miyata, K., Yoshizumi, M., Kagami, S., Kondo, S., Kiyomoto, H., Shokoji, T., Kimura, S., et al. (2004) · Hypertension · doi:10.1161/01.hyp.0000118519.66430.22 · Cited by 314
White, W. B., Duprez, D., St Hillaire, R., Krause, S., Roniker, B., Kuse-Hamilton, J., & Weber, M. A. (2003) · Hypertension · doi:10.1161/01.hyp.0000067463.13172.ea · Cited by 295
Requirement of Rac1 in the development of cardiac hypertrophy
Satoh, M., Ogita, H., Takeshita, K., Mukai, Y., Kwiatkowski, D. J., & Liao, J. K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510444103 · Cited by 272
Kurtz, T. W., Griffin, K. A., Bidani, A. K., Davisson, R. L., & Hall, J. E. (2005) · Hypertension · doi:10.1161/01.hyp.0000150857.39919.cb · Cited by 263
Nagase, M., Shibata, S., Yoshida, S., Nagase, T., Gotoda, T., & Fujita, T. (2006) · Hypertension · doi:10.1161/01.hyp.0000222003.28517.99 · Cited by 248
Self-citationAldosterone Activates Vascular p38MAP Kinase and NADPH Oxidase Via c-Src
Callera, G. E., Touyz, R. M., Tostes, R. C., Yogi, A., He, Y., Malkinson, S., & Schiffrin, E. L. (2005) · Hypertension · doi:10.1161/01.hyp.0000154365.30593.d3 · Cited by 246
Leong, M. L. L., Maiyar, A. C., Kim, B., O'Keeffe, B. A., & Firestone, G. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211649200 · Cited by 242
Nagata, K., Obata, K., Xu, J., Ichihara, S., Noda, A., Kimata, H., Kato, T., Izawa, H., Murohara, T., & Yokota, M. (2006) · Hypertension · doi:10.1161/01.hyp.0000203772.78696.67 · Cited by 223
Brain mineralocorticoid receptors and centrally regulated functions
de Kloet, E. R., van Acker, S. A. B. E., Sibug, R. M., Oitzl, M. S., Meijer, O. C., Rahmouni, K., & de Jong, W. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00971.x · Cited by 218
Miyata, K., Rahman, M., Shokoji, T., Nagai, Y., Zhang, G.-X., Sun, G.-P., Kimura, S., Yukimura, T., Kiyomoto, H., Kohno, M., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005040390 · Cited by 212
Relative Glomerular Hyperfiltration in Primary Aldosteronism
Ribstein, J., Du Cailar, G., Fesler, P., & Mimran, A. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004100878 · Cited by 201
Iglarz, M., Touyz, R. M., Viel, É. C., Amiri, F., & Schiffrin, E. L. (2004) · American Journal of Hypertension · doi:10.1016/s0895-7061(04)00811-8 · Cited by 172
Kretzler, M., Koeppen-Hagemann, I., & Kriz, W. (1994) · Virchows Archiv · doi:10.1007/bf00230355 · Cited by 158
Iglarz, M., Touyz, R. M., Viel, É. C., Amiri, F., & Schiffrin, E. L. (2004) · PubMed · Cited by 158
Nagai, Y., Miyata, K., Sun, G.-P., Rahman, M., Kimura, S., Miyatake, A., Kiyomoto, H., Kohno, M., Abe, Y., Yoshizumi, M., et al. (2005) · Hypertension · doi:10.1161/01.hyp.0000174593.88899.68 · Cited by 158
Quinkler, M. O., Zehnder, D., Eardley, K. S., Lepenies, J., Howie, A. J., Hughes, S. V., Cockwell, P., Hewison, M., & Stewart, P. M. (2005) · Circulation · doi:10.1161/circulationaha.105.539122 · Cited by 146
Nephrin and podocin dissociate at the onset of proteinuria in experimental membranous nephropathy
Nakatsue, T., Koike, H., Han, G. D., Suzuki, K., Miyauchi, N., Yuan, H., Salant, D. J., Gejyo, F., Shimizu, F., & Kawachi, H. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00328.x · Cited by 121
Self-citationShibata, S., Nagase, M., & Fujita, T. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005050571 · Cited by 114
Self-citationMatsumura, Y., Hashimoto, N., Taira, S., Kuro, T., Kitano, R., Ohkita, M., Opgenorth, T. J., & Takaoka, M. (1999) · Hypertension · doi:10.1161/01.hyp.33.2.759 · Cited by 113
Hypertension-Related Renal Injury: A Major Contributor to End-Stage Renal Disease
Walker, W. G. (1993) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)70183-x · Cited by 104
Albuminuria in untreated patients with primary aldosteronism or essential hypertension
Halimi, J., & Mimran, A. (1995) · Journal of Hypertension · doi:10.1097/00004872-199512010-00054 · Cited by 89
Protective Effect of Potassium Against the Hypertensive Cardiac Dysfunction
Matsui, H., Shimosawa, T., Uetake, Y., Wang, H., Ogura, S., Kaneko, T., Liu, J., Ando, K., & Fujita, T. (2006) · Hypertension · doi:10.1161/01.hyp.0000232617.48372.cb · Cited by 89
Self-citationVariable expression of desmin in rat glomerular epithelial cells.
Yaoita, E., Kawasaki, K., Yamamoto, T. S., & Kihara, I. (1990) · Europe PMC (PubMed Central) · Cited by 88
Nagase, M., Kaname, S., NAGASE, T., Wang, G., Ando, K., Sawamura, T., & Fujita, T. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v11101826 · Cited by 84
Self-citationVallon, V., & Lang, F. J. W. (2004) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200501000-00010 · Cited by 74
SGK1 as a determinant of kidney function and salt intake in response to mineralocorticoid excess
Vallon, V., Huang, D. Y., Grahammer, F., Wyatt, A. W., Oßwald, H., Wulff, P., Kuhl, D., & Lang, F. J. W. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00731.2004 · Cited by 74
Kumar, J. M., Brooks, D. P., Olson, B. A., & Laping, N. J. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v10122488 · Cited by 69
Dietary Salt Regulates Renal SGK1 Abundance: Relevance to Salt Sensitivity in the Dahl Rat
Farjah, M., Roxas, B. P., Geenen, D. L., & Danziger, R. S. (2003) · Hypertension · doi:10.1161/01.hyp.0000063885.48344.ea · Cited by 67
Hou, J., Speirs, H. J. L., Seckl, J. R., & Brown, R. W. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000013702.73570.3b · Cited by 60
Up-Regulation of the Human Serum and Glucocorticoid-Dependent Kinase 1 in Glomerulonephritis
Friedrich, B., Wärntges, S., Klingel, K., Sauter, M., Kandolf, R., Risler, T., Muller, G. A., Witzgall, R., Kriz, W., Gröne, H., et al. (2002) · Kidney & Blood Pressure Research · doi:10.1159/000066794 · Cited by 40
Cited by
Oxidant Mechanisms in Renal Injury and Disease
Ratliff, B. B., Abdulmahdi, W., Pawar, R., & Wolin, M. S. (2016) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6665 · Cited by 694
Podocyte injury and its consequences
Nagata, M. (2016) · Kidney International · doi:10.1016/j.kint.2016.01.012 · Cited by 569
Effects of tempol and redox-cycling nitroxides in models of oxidative stress
Wilcox, C. S. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.01.003 · Cited by 465
Shibata, S., Nagase, M., Yoshida, S., Kawarazaki, W., Kurihara, H., Tanaka, H., Miyoshi, J., Takai, Y., & Fujita, T. (2008) · Nature Medicine · doi:10.1038/nm.1879 · Cited by 459
Self-citationContribution of aldosterone to cardiovascular and renal inflammation and fibrosis
Brown, N. J. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.110 · Cited by 451
Metadata
- Authors
- Shibata, S., Nagase, M., Yoshida, S., Kawachi, H., & Fujita, T.
- Venue
- Hypertension
- Published
- 2007-02
- Volume
- 49
- Issue
- 2
- Pages
- 355-364
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2152187665
- Cited by
- 362
- References
- 39
- FWCI
- 19.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.